GDS Wealth Management Purchases 26,876 Shares of HealthEquity, Inc. $HQY

Key Points

• GDS Wealth Management increased its holdings in HealthEquity, Inc. by 65.3%, purchasing an additional 26,876 shares, bringing their total ownership to 68,007 shares valued at approximately $6 million.
• Insider transactions revealed significant stock sales, with Elimelech Rosner selling 58,000 shares and Jon Kessler selling 134,183 shares, both representing notable decreases in their ownership stakes.
• HealthEquity received numerous analyst upgrades, with Bank of America raising its price target from $110 to $125, and the firm currently holds a consensus rating of "Buy" with a target price of $118.55.

GDS Wealth Management grew its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 65.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 68,007 shares of the company's stock after acquiring an additional 26,876 shares during the quarter. GDS Wealth Management owned 0.08% of HealthEquity worth $6,010,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in HQY. Versant Capital Management Inc bought a new stake in shares of HealthEquity in the 1st quarter worth about $28,000. Transce3nd LLC acquired a new position in HealthEquity in the fourth quarter valued at about $29,000. Larson Financial Group LLC grew its stake in HealthEquity by 1,366.0% during the first quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after buying an additional 642 shares during the last quarter. BI Asset Management Fondsmaeglerselskab A S bought a new stake in HealthEquity during the first quarter worth about $65,000. Finally, Whipplewood Advisors LLC increased its holdings in shares of HealthEquity by 5,060.0% during the first quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after buying an additional 759 shares in the last quarter. Institutional investors own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on HQY shares. JMP Securities boosted their target price on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Royal Bank Of Canada boosted their price objective on HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research note on Wednesday, June 4th. Barrington Research increased their target price on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, June 5th. The Goldman Sachs Group raised their target price on HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a research note on Wednesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and an average price target of $118.55.

HealthEquity Stock Down 1.4%

Shares of HQY traded down $1.2750 during midday trading on Monday, hitting $88.5450. The stock had a trading volume of 211,130 shares, compared to its average volume of 1,003,700. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. HealthEquity, Inc. has a twelve month low of $73.84 and a twelve month high of $116.65. The company has a 50 day simple moving average of $96.78 and a two-hundred day simple moving average of $96.43. The firm has a market cap of $7.66 billion, a price-to-earnings ratio of 64.59, a price-to-earnings-growth ratio of 1.39 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.16. The company had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. During the same period in the prior year, the business posted $0.80 EPS. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 58,000 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. The trade was a 43.38% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president owned 53,225 shares in the company, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock worth $32,705,007 over the last ninety days. 1.50% of the stock is currently owned by corporate insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.